Anvisa suspends import of inputs Indian company Lupin Limited

Anvisa suspends import of inputs Indian company Lupin Limited

May 13, 2015 - Anvisa suspended imports of all beta-lactam cephalosporin pharmaceutical ingredients and all imported drugs that were manufactured using these inputs, which are manufactured by the Indian company Lupin Limited.

Analysis considered unsatisfactory inputs. Furthermore, irregularities were detected during the inspection for verification of Good Manufacturing Practices.

The measure is in Resolution No. 1430, published on Wednesday (13/5) in the Official Gazette (DOU).

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.